Cosette Pharmaceuticals launches first generic CIPRO HC with 180 Days market exclusivity
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
The approval comes with 180 days of Competitive Generic Therapy (CGT) exclusivity,
This marks the first partnership between Pfizer and Cipla in India
The U.S. oncology market is projected to soar from $81 billion in 2025 to $212 billion by 2034
The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo and Evfraxy) in Europe starting December 2, 2025
LANXESS Biosecurity Solutions aims to deliver “advanced disinfection and hygiene solutions to support Indian farmers in maintaining healthier and safer farm environments
Winlevi is authorized in EU for the treatment of acne vulgaris
The company says the innovation delivers stronger moisture protection for highly sensitive drug molecules
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
Subscribe To Our Newsletter & Stay Updated